BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12237315)

  • 1. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells.
    Hotokezaka H; Sakai E; Kanaoka K; Saito K; Matsuo K; Kitaura H; Yoshida N; Nakayama K
    J Biol Chem; 2002 Dec; 277(49):47366-72. PubMed ID: 12237315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
    Lee SE; Woo KM; Kim SY; Kim HM; Kwack K; Lee ZH; Kim HH
    Bone; 2002 Jan; 30(1):71-7. PubMed ID: 11792567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).
    Matsumoto M; Sudo T; Saito T; Osada H; Tsujimoto M
    J Biol Chem; 2000 Oct; 275(40):31155-61. PubMed ID: 10859303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor.
    Matsumoto M; Sudo T; Maruyama M; Osada H; Tsujimoto M
    FEBS Lett; 2000 Dec; 486(1):23-8. PubMed ID: 11108836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
    Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
    Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation.
    Kim HH; Chung WJ; Lee SW; Chung PJ; You JW; Kwon HJ; Tanaka S; Lee ZH
    Exp Cell Res; 2003 Oct; 289(2):368-77. PubMed ID: 14499638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
    Fukazawa H; Noguchi K; Murakami Y; Uehara Y
    Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function.
    Li X; Udagawa N; Itoh K; Suda K; Murase Y; Nishihara T; Suda T; Takahashi N
    Endocrinology; 2002 Aug; 143(8):3105-13. PubMed ID: 12130576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
    Zauli G; Rimondi E; Nicolin V; Melloni E; Celeghini C; Secchiero P
    Blood; 2004 Oct; 104(7):2044-50. PubMed ID: 15213096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils.
    Dewas C; Fay M; Gougerot-Pocidalo MA; El-Benna J
    J Immunol; 2000 Nov; 165(9):5238-44. PubMed ID: 11046057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid.
    Ariyoshi W; Takahashi T; Kanno T; Ichimiya H; Takano H; Koseki T; Nishihara T
    J Biol Chem; 2005 May; 280(19):18967-72. PubMed ID: 15757905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori heat-shock protein 60 induces interleukin-8 via a Toll-like receptor (TLR)2 and mitogen-activated protein (MAP) kinase pathway in human monocytes.
    Zhao Y; Yokota K; Ayada K; Yamamoto Y; Okada T; Shen L; Oguma K
    J Med Microbiol; 2007 Feb; 56(Pt 2):154-164. PubMed ID: 17244794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
    Lee KH; Hyun MS; Kim JR
    Clin Exp Metastasis; 2003; 20(6):499-505. PubMed ID: 14598883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression.
    Karsdal MA; Hjorth P; Henriksen K; Kirkegaard T; Nielsen KL; Lou H; Delaissé JM; Foged NT
    J Biol Chem; 2003 Nov; 278(45):44975-87. PubMed ID: 12933809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEK activity regulates negative selection of immature CD4+CD8+ thymocytes.
    Bommhardt U; Scheuring Y; Bickel C; Zamoyska R; Hünig T
    J Immunol; 2000 Mar; 164(5):2326-37. PubMed ID: 10679067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by "MEK-specific" inhibitors PD 098059 and U0126 in differentiating HL60 cells.
    Wang X; Studzinski GP
    Exp Cell Res; 2001 Aug; 268(2):294-300. PubMed ID: 11478855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
    Zhang Z; Jimi E; Bothwell AL
    J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.